Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-22-017438
Filing Date
2022-06-17
Accepted
2022-06-17 16:22:51
Documents
1
Period of Report
2022-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165549734296466.html 4  
1 FORM 4 wf-form4_165549734296466.xml 4 3794
  Complete submission text file 0001628280-22-017438.txt   5297
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Issuer) CIK: 0001501697 (see all company filings)

EIN.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ABPRO CORPORATION 65 CUMMINGS PARK DRIVE WOBURN MA 01801
Business Address
Mostafa Adam S. (Reporting) CIK: 0001738081 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38295 | Film No.: 221024169